📰 Jack Cox News
Page 2 - Jack Cox News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jack Cox. Real-time updates on events, politics, business and more.
April 12, 2024
Check out the scores and top performances from Thursday’s high school baseball, softball and boys volleyball action.
April 1, 2024
/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
February 23, 2024
SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development...
February 22, 2024
Now, Dallas child and adult care facilities can open up in more areas of the city than before.
January 31, 2024
Company to reprioritize resources allocated to ADUHELM® (aducanumab-avwa) to advance LEQEMBI® (lecanemab-irmb) and to develop new treatment modali...
January 10, 2024
- Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta monoclonal antibody LEQEMBI has been approved in China as a treatment of mild cognitive...
December 20, 2023
City Council members and residents turned out yesterday to oppose the building of duplexes, triplexes and fourplexes near single family homes.
December 14, 2023
ZURZUVAE, the first and only oral, once-daily, 14-day treatment course, has shown to provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3 for women with PPDPatient support program, ZURZUVAE For You, and financial assistance available to eligible women with PPD prescribed ZURZUVAEPatients...
December 13, 2023
TOKYO and CAMBRIDGE, Mass., December 12, 2023 - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta monoclonal antibody LEQEMBI®...
November 6, 2023
Accomplished executive brings deep expertise leading global financial organizations and overseeing successful business transformationCAMBRIDGE, Mass., Nov. 06, 2023 -- Biogen Inc. today announced...